■ 学術雑誌
原著
|
1.
|
Ikoma T, Matsumoto T, Boku S, Motoki Y, Kinoshita H, Kosaka H, Kaibori M,
Inoue K, Sekimoto M, Fujisawa T, Iwai H, Naganuma M, Tanizaki H, Hisamatsu Y,
Okada H, Kurata T.:
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study.
Cancer immunology, immunotherapy : CII
73
(7)
:126
, 2024
|
2.
|
Nakamura N, Mastsuno Y, Aoi K, Kosaka H, Kobayashi S, Takahashi Y, Tahara T,
Noda Y, Tsuta K, Naganuma M.:
Hepatic Sarcoidosis Mimicking a Metastatic Tumor: A Case Report.
Internal medicine (Tokyo, Japan)
:Online ahead of print
, 2025
|
3.
|
Rimini M, Stefanini B, Tada T, Suda G, Shimose S, Kudo M, Finkelmeier F, Yoo
C, Presa J, Amadeo E, Genovesi V, De Grandis MC, Iavarone M, Marra F, Foschi F,
Tamburini E, Rossari F, Vitiello F, Bartalini L, Soldà C, Tovoli F, Vivaldi C,
Lonardi S, Silletta M, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Himmelsbach V,
Montes M, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama
K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa
T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T,
Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui
A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi
Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Persano M, Camera S, Foti S,
Aldrighetti L, Cascinu S, Casadei-Gardini A, Piscaglia F.:
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver international
44
(5)
:1108
-1125
, 2024
|
4.
|
Promsorn P, Yamaguchi T, Kosaka H, Aoi K, Yoshida K, Matsushima H, Matsui K,
Shimoda S, Kaibori M, Naganuma M.:
Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib.
Molecular and clinical oncology
21
(3)
:63
, 2024
|
5.
|
Nakatake R, Funatsuki T, Koshikawa Y, Okuyama T, Ishizaki M, Takekita Y, Kato
M, Kitade H:
C reactive protein albumin ratio as a new predictor of postoperative delirium after cholecystectomy for acute cholecystitis.
Scientific reports
14
(1)
:21704
, 2024
|
6.
|
Kosaka H, Matsui K, Ikeura T, Ito T, Ohe C, Kono Y, Matsushima H, Yamamoto H,
Sekimoto M, Kaibori M.:
Prognostic impact of combination therapy with gemcitabine and cisplatin plus S-1 and subsequent conversion surgery for initially unresectable upper biliary tract cancers.
Surgery today
55
(3)
:351
-359
, 2025
|
|